List of Tables
    Table 1. Bio Similars/Subsequent Entry Biologic Market Opportunities & Trends in Global Market
    Table 2. Bio Similars/Subsequent Entry Biologic Market Drivers in Global Market
    Table 3. Bio Similars/Subsequent Entry Biologic Market Restraints in Global Market
    Table 4. Key Players of Bio Similars/Subsequent Entry Biologic in Global Market
    Table 5. Top Bio Similars/Subsequent Entry Biologic Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Bio Similars/Subsequent Entry Biologic Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Bio Similars/Subsequent Entry Biologic Product Type
    Table 9. List of Global Tier 1 Bio Similars/Subsequent Entry Biologic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Bio Similars/Subsequent Entry Biologic Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Bio Similars/Subsequent Entry Biologic Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Bio Similars/Subsequent Entry Biologic Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Bio Similars/Subsequent Entry Biologic Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Bio Similars/Subsequent Entry Biologic Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2023-2028
    Table 30. Sun Pharma Corporate Summary
    Table 31. Sun Pharma Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 32. Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 33. Synthon Pharmaceuticals Corporate Summary
    Table 34. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 35. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 36. Teva Pharmaceutical Industries Corporate Summary
    Table 37. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 38. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 39. LG Life Sciences Corporate Summary
    Table 40. LG Life Sciences Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 41. LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 42. Celltrion Biocon Corporate Summary
    Table 43. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 44. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 45. Hospira Corporate Summary
    Table 46. Hospira Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 47. Hospira Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 48. Merck Corporate Summary
    Table 49. Merck Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 50. Merck Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 51. Biogen idec Corporate Summary
    Table 52. Biogen idec Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 53. Biogen idec Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 54. Genentech (Roche) Corporate Summary
    Table 55. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 56. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 57. Pfizer Corporate Summary
    Table 58. Pfizer Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 59. Pfizer Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 60. Celltrion Corporate Summary
    Table 61. Celltrion Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 62. Celltrion Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 63. Biocon Corporate Summary
    Table 64. Biocon Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 65. Biocon Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 66. Amgen Corporate Summary
    Table 67. Amgen Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 68. Amgen Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 69. Samsung Biologics Corporate Summary
    Table 70. Samsung Biologics Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 71. Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 72. Mylan Corporate Summary
    Table 73. Mylan Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 74. Mylan Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 75. Dr. Reddy's Laboratories Corporate Summary
    Table 76. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 77. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 78. Stada Arzneimittel AG Corporate Summary
    Table 79. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 80. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 81. AbbVie Corporate Summary
    Table 82. AbbVie Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 83. AbbVie Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 84. Sanofi-Aventis Corporate Summary
    Table 85. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 86. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 87. Johnson & Johnson Corporate Summary
    Table 88. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 89. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 90. Novo Nordisk Corporate Summary
    Table 91. Novo Nordisk Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 92. Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 93. Eli Lilly Corporate Summary
    Table 94. Eli Lilly Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 95. Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 96. Novartis Corporate Summary
    Table 97. Novartis Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 98. Novartis Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 99. 3sbio Corporate Summary
    Table 100. 3sbio Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 101. 3sbio Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 102. Biotech Corporate Summary
    Table 103. Biotech Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 104. Biotech Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 105. Gelgen Corporate Summary
    Table 106. Gelgen Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 107. Gelgen Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 108. Innovent Corporate Summary
    Table 109. Innovent Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 110. Innovent Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 111. Dong Bao Corporate Summary
    Table 112. Dong Bao Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 113. Dong Bao Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
    Table 114. Ganlee Corporate Summary
    Table 115. Ganlee Bio Similars/Subsequent Entry Biologic Product Offerings
    Table 116. Ganlee Bio Similars/Subsequent Entry Biologic Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Bio Similars/Subsequent Entry Biologic Segment by Type in 2021
    Figure 2. Bio Similars/Subsequent Entry Biologic Segment by Application in 2021
    Figure 3. Global Bio Similars/Subsequent Entry Biologic Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Bio Similars/Subsequent Entry Biologic Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Bio Similars/Subsequent Entry Biologic Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Bio Similars/Subsequent Entry Biologic Revenue in 2021
    Figure 8. By Type - Global Bio Similars/Subsequent Entry Biologic Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Bio Similars/Subsequent Entry Biologic Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Bio Similars/Subsequent Entry Biologic Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Bio Similars/Subsequent Entry Biologic Revenue Market Share, 2017-2028
    Figure 12. US Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share, 2017-2028
    Figure 16. Germany Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 17. France Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Bio Similars/Subsequent Entry Biologic Revenue Market Share, 2017-2028
    Figure 24. China Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 28. India Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Bio Similars/Subsequent Entry Biologic Revenue Market Share, 2017-2028
    Figure 30. Brazil Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share, 2017-2028
    Figure 33. Turkey Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Bio Similars/Subsequent Entry Biologic Revenue, (US$, Mn), 2017-2028
    Figure 37. Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Hospira Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Merck Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Biogen idec Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Pfizer Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Celltrion Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Biocon Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Amgen Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 51. Mylan Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 52. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 53. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 54. AbbVie Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 55. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 56. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 57. Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 58. Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 59. Novartis Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 60. 3sbio Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 61. Biotech Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 62. Gelgen Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 63. Innovent Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 64. Dong Bao Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 65. Ganlee Bio Similars/Subsequent Entry Biologic Revenue Year Over Year Growth (US$, Mn) & (2017-2022)